CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Grant or award Director acquired 2,831 shares (grant or award)
- 4 Open-market buy President & CFO bought 12,385 shares at $1.35 ($16,681)
- 4 Open-market buy President & CFO bought 81,000 shares at $1.24 ($100,173)
- 4 Grant or award Director acquired 2,277 shares (grant or award)
- 4 Grant or award Director acquired 2,086 shares (grant or award)
- 4 Grant or award See Remarks acquired 1,578 shares (grant or award)
- 4 Grant or award See Remarks acquired 6,369 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 1,574 shares (grant or award)
- 4 Grant or award Director acquired 9,026 shares (grant or award)
- 4 Grant or award Director acquired 1,597 shares (grant or award)
- 4 Grant or award Executive Chair of the Board acquired 40,000 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Grant or award Director acquired 11,330 shares (grant or award)
- 4 Grant or award Director acquired 10,000 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
Page 11 of 33 · 648 filings